TargetMol
Dolutegravir sodium salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.
More Information
Supplier Page
Darunavir
50 mg
| Purity Not Available
TargetMol
Darunavir is an HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.
More Information
Supplier Page
Darunavir
25 mg
| Purity Not Available
TargetMol
Darunavir is an HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.
More Information
Supplier Page
Darunavir
10 mg
| Purity Not Available
TargetMol
Darunavir is an HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS.
More Information
Supplier Page
TargetMol
Efinaconazole(KP-103) is an Azole Antifungal currently under development as a topical treatment for onychomycosis.
More Information
Supplier Page
TargetMol
Efinaconazole(KP-103) is an Azole Antifungal currently under development as a topical treatment for onychomycosis.
More Information
Supplier Page
Ro-3306
5 mg
| Purity Not Available
TargetMol
RO-3306 is a selectivity ATP-competitive CDK1 inhibitor (Ki: 20 nM). The selectivity of RO-3306 for CDK1 is >15-fold higher than a diverse panel of human kinases.
More Information
Supplier Page
Ro-3306
50 mg
| Purity Not Available
TargetMol
RO-3306 is a selectivity ATP-competitive CDK1 inhibitor (Ki: 20 nM). The selectivity of RO-3306 for CDK1 is >15-fold higher than a diverse panel of human kinases.
More Information
Supplier Page
Ro-3306
10 mg
| Purity Not Available
TargetMol
RO-3306 is a selectivity ATP-competitive CDK1 inhibitor (Ki: 20 nM). The selectivity of RO-3306 for CDK1 is >15-fold higher than a diverse panel of human kinases.
More Information
Supplier Page
Ro-3306
100 mg
| Purity Not Available
TargetMol
RO-3306 is a selectivity ATP-competitive CDK1 inhibitor (Ki: 20 nM). The selectivity of RO-3306 for CDK1 is >15-fold higher than a diverse panel of human kinases.
More Information
Supplier Page